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ABSTRACT

PERI-IMPLANTITIS RISK PREDICTION USING A COMPUTER
BASED PERIODONTAL RISK CALCULATOR TOOL: A
RETROSPECTIVE STUDY.
Walaa Al Zaibak, BDS
Marquette University, 2020
Introduction: Although literature is abundant on the diagnosis and management of periimplantitis after it has occurred, to our current knowledge there are no studies that have
specifically looked into the relationship between peri-implantitis and the periodontal risk
assessment tool used for natural dentitions.
Material and Methods: In this retrospective study, the patient population included
patients (>20 years of age) who had implants placed and restored at Marquette University
School of Dentistry (MUSOD) from 2008 to 2016. Further, the restored implants in these
patients must have been in function for at least one year and followed up in the school
with clinical and radiographic examinations. Patients excluded from the study were those
who had radiation therapy, or any patients who did not have acceptable radiographs for
proper documentation. Before collecting data from patients' existing records, approval
was obtained from MUSoD's Institutional Review Board. Patient records were screened
from a list of 1,496 patients who had 3,032 implants placed at the school between the
mentioned period. A total of 112 implants placed in 83 patients were included for
analysis.
Results: All cases with PRC of 1 were in the control group while all cases with PRC of
4 and 5 were in the test group. Average proximal bone loss was significantly
correlated with PRC scores. The patients with higher PRC scores had more average
proximal bone loss when measured radiographically. Average proximal bone loss in
the control group was 0.11mm and in the peri-implantitis group was 2.48 mm.
Conclusions: Periodontal risk calculator may be used to predict risk of periimplantitis
occurrence and degree of radiographic proximal bone loss around dental implants.
Higher PRC scores were correlated with higher bone loss and lower PRC scores were
correlated with reduced severity of bone loss.
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INTRODUCTION

Dental implants have been widely used as a standard treatment option for restoring missing
teeth as an alternative to removable and fixed dental prosthesis. In the year 2000, it was
reported that an estimate of 300,000 to 428,000 implants were placed yearly.1 A
significantly higher success rate is observed for implants placed in the mandibular than the
maxillary arch.2 Studies have previously described specific criteria for evaluating implant
success. These include an absence of any signs and symptoms such as pain, infection,
neuropathies, vital structure violation, mobility, peri-implant radiolucency, or progressive
bone loss.1
Dental implants have been shown to achieve almost 85-95% 10-year success rate when
placed in complete and partially edentulous maxillary and mandibular arches.3 The success
of implants is directly correlated with a process called osseointegration. Osseointegration
at the light microscopic level, is defined as a direct structural connection between living
bone and functionally loaded implants.4
Endosseous dental implants are available in a variety of lengths and widths to suit different
clinical situations.1 Most implants today have a roughened surface as compared to
previously used smooth or machined surfaces. Roughened surface implants are thought to
be superior to the smooth surface implants because roughened surface implants show
higher bone to implant contacts with more significant potential for osseointegration. Either
coating or non-coating techniques may be used to create the rough surfaces on implants.
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Peri-implant disease:
A large number of patients requiring implant therapy have a history of chronic
periodontitis. Restoring these patients with dental implants has become a common practice.
Long-term studies have shown patients with chronic periodontitis to have increased
susceptibility to peri-implant complications, most common being peri-implant mucositis
and peri-implantitis. Extensive literature has reported poor oral hygiene, smoking, and
history of chronic periodontal disease to be risk indicators for the development of periimplantitis. Also, it was found that patients with history of periodontitis had a significantly
greater prevalence of peri-implant sites with plaque, bleeding on probing and deep pocket
depth.5,6
Peri-implant mucositis is defined as a reversible inflammation resulting in bleeding on
probing without peri-implant bone loss. Peri-implantitis is defined as an inflammation
affecting hard and soft tissues around a dental implant. It is considered acceptable to have
1.5mm of bone loss during the first year of function as the biologic width establishes itself
around the implant abutment junction and subsequently, 0.2mm loss yearly.7 Berglundh
and Lindhe in 1996 stated bone resorption may occur to allow for formation of a stable soft
tissue attachment and maintain a minimum width of peri-implant mucosa.8 Several criteria
have been described in the literature for diagnosis of peri-implantitis. According to the
2017 world workshop on the classification of periodontal and peri-implant diseases and
conditions, peri-implantitis is a plaque associated pathological condition that leads to
progressive loss of bone around dental implants.9 For a diagnosis of peri-implantitis, the
presence of bleeding on probing and/or suppuration on probing, increased probing depth
and bone loss past the level of expected initial remodeling must be present. Diagnosis may
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also be made in the absence of previous records if there is ≥ 6 mm of probing depth and ≥
3 mm of radiographic bone loss around the implant with clinical bleeding on probing and/or
suppuration.9 Onset of peri-implantitis usually occurs 2-3 years after implant loading.10 The
amount of initial remodeling that occurs after implant placement is variable and may be
affected by several local and systemic factors, therefore baseline radiographs should ideally
be made after the loading phase has occurred.9
Prevalence of peri-implant disease:
Prevalence of peri-implantitis has been reported by several studies. Buser and co-workers
assessed 303 tissue level implants, with sandblasted and acid etched surfaces, over 10 years
of function and found prevalence of peri-implantitis to be 1.8%.11 This low prevalence may
be partially related to the implant design, featuring a polished transmucosal collar and
internal connection. This type of design moves the microgap between the implant and
abutment coronally, away from the crestal bone and so should theoretically reduce the
bacterial challenge on the crestal bone.5,12 However, this displacement of the implantabutment microgap is not exclusive to the tissue level design and may also be accomplished
by a horizontal offset in bone level implants commonly referred to as platform switching.
Platform switching has been shown in the literature to reduce the risk of peri-implant bone
loss.13
Frisch and colleagues followed up on 36 non-smoking patients with implants placed for ≥
10 years and found prevalence of peri-implantitis in maxillary and mandibular implant
supported overdentures was 9.1% at the patient level after a mean follow up of 14 years.14
Marrone and wo-workers, in 2012, assessed prevalence of peri-mucositis peri-implantitis
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in 103 patients with a total of 266 implants with an average of 8.5 years of function. Their
results showed 38 % of implants had peri-implant mucositis while 23 % had periimplantitis.15 The varying ranges in prevalence of peri-implantitis reported in the literature
may be, in part, attributed to the lack of consensus in diagnostic criteria and the
heterogenicity in the studies.16 Other factors that may play a role in the varying ranges
reported include different implant systems, designs and surfaces as well as the varying
experience levels of clinicians placing these implants.
Renvert and co-workers in 2017 reported results for 86 patients who had 351 Branemark
dental implants placed and followed up for 20-26 years. They found 54.7% of implant
developed peri-implant mucositis, while 22.1 % developed peri-implantitis. They also
found that smoking, a diagnosis of peri-implant mucositis and radiographic evidence of
periodontitis were not significantly correlated with developing peri-implantitis. Patients
who had 3 or more implants were at higher risk of developing peri-implantitis.17
Risk determination for peri-implant disease:
Both peri-implant mucositis and peri-implantitis may be caused by inadequate oral hygiene
and plaque or residual cement from crown placement.7 Peri-implant mucositis may be a
precursor to peri-implantitis. However, it does not always progress in that manner.18 The
shift from peri-implant mucositis to peri-implantitis is not fully understood, however it has
been proposed that it is likely to be similar to the progression from gingivitis to
periodontitis.19
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Plaque is considered to be a principal etiological factor for peri-implantitis. This evidence
is mostly derived from observational studies showing that poor oral hygiene and negligence
in maintenance care increases the risk of peri-implantitis.9
Treatment of peri-implantitis has the same end goal as treatment of periodontitis, that is to
prevent the progression of bone loss. Successful therapy should ideally also eliminate
pockets and bleeding on probing, indicating clinical resolution of inflammation.19
For the longest time, an accepted patient care practice was to focus on restoring oral health
rather than preventing disease. A relatively new trend has emerged in using patient-specific
risk assessment to prevent progression of periodontal disease or to enable primary
prevention of disease by using a computer-based tool known as Periodontal risk calculator
(PRC). PRC has been validated as a tool that provides an algorithm that seems to predict
alveolar bone and tooth loss.20 This tool is being used as an aid in the treatment planning
and management of dental patients. The PRC is based on a proprietary algorithm that uses
commonly known risk factors affecting patients’ susceptibility for developing periodontal
disease. It helps generate patient specific treatment options to strategically reduce risk
factors and repair existing damage. Once the PRC assessment is completed, each patient is
given a score from 1 (low risk) to 5 (high risk). The PRC protocol requires recording patient
history and completing a periodontal examination.20
Although literature is abundant on the diagnosis and management of peri-implantitis after
it has occurred, to our current knowledge there are no studies that have specifically looked
into the relationship between peri-implantitis and the periodontal risk assessment tool used
for natural dentitions.
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BACKGROUND AND SIGNIFICANCE

Implants are regularly used to replace periodontally involved teeth and are at higher risk of
peri-implant disease when placed in patients with a history of periodontitis.5 Peri-implant
tissues tend to be more prone to inflammation as compared to periodontal tissue supporting
natural teeth. The susceptibility of peri-implant tissue is especially true when looking at
two-piece, non-platform switched implants.5,13 The micro-gap present between the implant
and the abutment creates a zone of chronic inflammatory cells around the peri-implant
tissues. One-piece implants have been reported to have an inflammation free peri-implant
tissue.5

Bacterial Biofilm
To assess the bacterial biofilm of peri-implantitis Shibli and colleagues, in 2008, looked at
the microbiological composition of supra- and subgingival plaque samples collected from
44 subjects with peri-implantitis affecting a single implant, who also had a healthy implant
as a control. All the implants had been in function for a minimum of 2 years before a
diagnosis of peri-implantitis was made. Supra and subgingival plaque samples were
collected from the sites exhibiting the deepest pockets using sterile plastic curettes. All
samples were processed separately, and checkerboard DNA-DNA hybridization was done.
The results showed that the composition for both supra- and subgingival samples differed
significantly in peri-implantitis sites than in sites with healthy implants. Peri-implantitis
sites were associated with pathogenic periodontal bacterial species such as Porphyromonas
gingivalis, Treponema denticola, and Tannerella forsythia.21
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In 2011, Mombelli and co-workers reviewed 29 articles on the characteristics of biofilms
in peri-implant disease and found that biofilms in peri-implant disease were predominantly
gram-negative anaerobic flora similar to that seen in the subgingival environment of
chronic periodontitis. These include Fusobacterium spp. and Prevotella intermedia.22
Koyanagi and co-workers, in 2013, looked specifically at subgingival plaque specimens of
peri-implantitis sites and periodontitis sites. They used sterile paper points to collect
subgingival plaque samples from the deepest pockets of peri-implantitis sites and nonadjacent periodontitis sites in 6 patients. The paper points were inserted into the pockets
until resistance was felt for 30 seconds and then placed in a sterile tube containing 1ml of
distilled water and taken for processing and incubation. After quantitative analysis, they
found that the prevalence of periodontally pathogenic bacteria was even higher at periimplantitis sites than at periodontitis sites.23
In 2014, Da Silva and colleagues further support previous studies in their findings. They
tested 20 subjects with peri-implantitis and periodontally healthy remaining dentition. Ten
of the subjects had healthy implants as well to act as a control. Samples were collected
from the deepest pocket sites using sterile Gracey curettes and then subjected to bacterial
lysis and Polymerase chain reaction amplification. Their results showed remarkable
differences in the composition of the subgingival biofilm between healthy and diseased
implants. The biofilm associated with peri-implantitis sites showed more pathogenic
bacterial species composition than healthy implant sites. These included some pathogenic
bacterial species associated with periodontitis but also some unexpected putative
pathogens.24
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Becker and co-workers, in 2014, aimed to assess mRNA signatures from tissue samples
excised from 22 patients isolating areas of peri-implantitis, periodontitis, and healthy
controls. They found signatures to be significantly different between peri-implantitis and
periodontitis sites. Furthermore, they found that the regulation of transcripts in periimplantitis tissues was mainly related to the innate immune response including cell surface
receptor signaling pathways and defense responses. Transcripts in periodontitis were
mainly related to bacterial responses including response to molecules of bacterial origin
and mononuclear cell proliferation.25
Yet another publication that supports a similarity between microbiota at peri-implantitis
sites and periodontitis sites comes from Waal and colleagues 2017 who conducted a
microbiological study comparing 85 patients suffering from peri-implantitis to 69 patients
with healthy peri-implant tissue using culturing techniques. Association of disease status
and various patient- and implant-level factors with microbial characteristics were explored.
Their findings showed that there was a strong association for the presence of
Porphyromonas gingivalis, Provetella intermedia, Tannerella forsythia, and Fusobacterium
nucleatum to peri-implantitis, which are commonly isolated bacteria in periodontal
disease.26
Schincaglia and co-workers conducted a study in 2017 to compare the clinical and
inflammatory response between natural teeth and implants after 2 weeks of impaired oral
hygiene practices. Their results showed that while implants accumulated less plaque
clinically, they displayed a trend towards more elevated inflammatory mediators. They also
found that the microbiome profile and community structure was similar for teeth and
implants.27
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Waal et al. 2017

-

periodontitis, and
healthy controls.

-

Bacterial response
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in periodontitis

85 patients with
peri-implantitis
69 patients with
healthy peri-implant
tissue
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Tannerella forsythia
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Table 1. Summary of Microbiological studies.
Factors associated with peri-implantitis:
Peri-implantitis may occur due to several factors. To investigate the prevalence, etiology,
and management of peri-implantitis and peri-mucositis Papathanasiou and co-workers
conducted a survey of 280 periodontists in 2016. They concluded that peri-implant disease
was commonly encountered in their practices in over 25% of the patients. They also
reported that there was an absence of standard therapeutic protocol in treating this
condition. There was a general agreement among the specialists that the etiology of periimplantitis was strongly correlated with oral hygiene and plaque, smoking, excess
subgingival cement, inadequate keratinized tissue, poor systemic health and noncompliance with maintenance schedule.28
Of the factors listed, excess cement left behind during prosthesis insertion has been of great
concern, and several authors have researched this area. Thomas Wilson, in 2009, examined
39 consecutive patients with signs of peri-implant disease using a dental endoscope. Fortytwo test implants with peri-implant disease and 20 clinically healthy control implants were
included. He found that excess cement was present in 81% of the test implants, and after
removal of excess cement, 76% of those showed complete resolution of inflammation. The
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findings of their study indicated that if excess cement was not left behind, cement-retained
restorations might not necessarily pose a more significant threat of peri-implantitis.
Another interesting finding of this study was that signs of peri-implant disease were found
to appear as early as four months after cementation of the final prosthesis and as late as
nine years or more. They questioned the predictability of the timeline for peri-implant
disease progression to peri-implantitis.29
Sailer and co-workers, in 2012, assessed the 5-year survival rate and complications of
cement vs. screw-retained implant restorations. One of their findings was that cemented
restorations displayed a higher incidence of peri-implantitis as compared to screw-retained
restorations.30
To assess whether single implant cemented restorations could be adequately evaluated
clinically and radiographically for excess cement and cleaned satisfactorily during the
insertion appointment, Linkevicius and colleagues, in 2013, conducted a clinical trial on
53 patients undergoing prosthetic replacement of a single tooth supported by an implant.
Implant restorations were fabricated to be cemented onto standard abutments intraorally
and cleaned until deemed acceptable clinically and radiographically, then finally removed
as one piece through pre-existing screw access opening in the crown. Areas of excess
cement were evaluated after crown removal and were correlated to the depth of the
cementation margin. The results showed that varying amounts of excess cement were
located on all restoration margins and that more remaining cement was found as the
margins were located deeper within the sulcus.31
Katafuchi and co-workers in 2017 conducted a cross sectional radiographic analysis of 168
implants placed in 83 patients to assess the influence of restoration contours on the
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prevalence of peri-implantitis. They reported that for bone level implants, there was a
significant correlation between peri-implantitis and emergence angles of >30 degrees. A
significant correlation was also found for peri-implantitis and convex emergence profiles.
When the emergence profile was both convex and at an angle > 30 degrees, peri-implantitis
prevalence was 37.8%.6 Yuseung Yi and colleagues, in 2020, conducted a similar study,
performing a retrospective analysis of 169 patients with a diagnosis of peri-implantitis to
assess the influence of prosthesis related factors on its occurrence. They also found a
statistically significant association between peri-implantitis and emergence angles of ≥ 30
degrees, as well as convex emergence profiles.32 These findings indicate that prosthesis
design and contours have significant impact on the health of peri-implant tissues.6,32
Several studies have looked for associations between peri-implantitis and periodontitis.
Karoussis and colleagues, in 2003, conducted a 10-year prospective study looking at 89
patients treated with implant therapy. They found that peri-implantitis was associated with
smoking, general health condition, full mouth attachment loss, and probing pocket depth
change over time.33
Ong and colleagues conducted a systematic review in 2008 that included nine studies
comparing implant outcomes in patients with a history of periodontitis versus nonperiodontitis patients. They found evidence that periodontitis patients experienced a higher
rate of soft and hard tissue peri-implant complications.34 This supports Karoussis’s findings
that peri-implantitis shows association with periodontitis and may similar risk factors.
Marrone and colleagues, in 2012, found that patients with active periodontitis were 1.98
times more likely to develop peri-implantitis compared to the control group.15
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On the other hand, Cho-Yan Lee and wo-workers conducted a clinical trial in 2011
comparing the prevalence of peri-implantitis among 30 periodontally compromised and 30
periodontally healthy patients with five years follow-up. They found that implants placed
in periodontally compromised patients displayed similar bone loss and peri-implantitis
levels to those placed in periodontally healthy patients, given that there was adequate
periodontal therapy and maintenance.35 This may indicate that the risk of developing periimplantitis may be controlled in the same way as periodontitis risk is controlled with
adequate therapy and regular maintenance. However, it must be noted that the sample size
in this study is relatively small and the patients were followed up over a short time frame
when considering peri-implantitis occurrence.
Since smoking is a significant risk factor for periodontitis, several studies have looked into
finding an association between smoking and peri-implantitis. Haas and colleagues, in 1996,
compared 107 smokers to 314 non-smokers with clinical and radiographic observations to
assess peri-implant tissues. They found that smoking resulted in a higher level of bone loss
around dental implants.36 Lindquist and colleagues, in 1997, found that there is a correlation
between the number of cigarettes smoked per day and the amount of bone loss
demonstrated around implants.37 Al Harthi and co-workers, in 2017, conducted a
retrospective study to investigate the prevalence of peri-implantitis in waterpipe smokers,
cigarette smokers, and non-smokers. The results showed that peri-implantitis was
significantly higher among waterpipe and cigarette smokers than non-smokers.38
As for an association between diabetes and peri-implantitis, Monje and colleagues
conducted a systematic review and meta-analysis in 2017, including 12 studies comparing
the risk of peri-implantitis in diabetic versus non-diabetic patients. These 12 studies
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comprised of 1,955 patients and 2892 implants. Among these patients, 12 patients were
pre‐diabetic, 468 had diabetes, and 1,487 did not have diabetes. The authors found that
diabetic patients had a 50% higher risk of developing peri-implantitis. They also found that
there was a dose-dependent relationship between baseline HBA1c level and the occurrence
of peri-implantitis.39 This finding could be an important factor in possibly using the PRC
for predicting peri-implantitis as the PRC risk scores account for the presence and level of
control in diabetes patients as part of their algorithm.40
Al Zahrani in 2008 conducted a systematic review of nine articles looking at implant
therapy in patients suffering from aggressive periodontitis. The study concluded that
aggressive periodontitis patients display bone loss around dental implants more often than
chronic periodontitis patients and periodontitis free patients. However, implant therapy was
still feasible in these patients.41
Lang & Berglundh in 2011, attributed peri-implantitis to several factors, including
iatrogenic factors such as excess remnant cement, inadequate abutment seating, over
contouring of implant restorations, implant malposition, and other technical
complications.42
Other factors that may be associated with bone loss around implants may include delayed
vs immediate placement implants, staging, need for bone grafting, loading protocols,
implant site and size and local infections.43,44 Biomechanical factors may include traumatic
surgical technique, overheating the osteotomy site during surgery and implant
overloading.43
Lin and colleagues, in 2018, conducted a retrospective analysis of 20,959 implants to assess
the risk factors associated with early and late implant loss. They found that late implant
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failures (after occlusal loading) were significantly more common in patients that had bone
augmentation procedures done.44
Shin and colleagues in 2006 showed that less crestal bone loss occurs around roughened
surface implants in comparison to machined surface implants.45 Depth of implant
placement may also play a role as demonstrated by Stein and co-workers in 2009. Implants
placed sub-crestally are more likely to experience bone loss at the coronal aspect of the
implants.46 Although their study did not include platform switched implants, this may still
be a relevant consideration when planning and placing implants.
Susarla and coworkers in 2008 compared 1-year survival rates of immediately loaded
implants versus implants loaded 3-6 months after placement. They found that immediately
loaded implants are 2.7 times more likely to fail at 1 year than conventionally loaded
implants. They also found tobacco use, maxillary implants and short implants were
associated with higher failure rates.47 Block and co-workers in 2009 assessed the effects of
immediate and delayed implant placement with provisionalization on bone and gingival
response in the maxillary anterior region. Their study showed that bone levels were similar
for both groups while more gingival recession was observed in the delayed placement
group.48 Several authors agreed that slight crestal bone loss after immediate implant
placement is an acceptable clinical outcome.49,51 Although other studies have shown that
immediate implants can have similar performance to implants in healed ridges. This may
be a testament to the technique sensitive nature of the procedure. Assuming adequate cases
selection and clinical implementation, it should be assumed that immediate implant
placement has similar outcomes to delayed placement.52
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Performing 1-stage versus 2-stage implant placement may also affect success rates of
dental implants. The 2-stage approach is considered by many to be the gold standard
protocol for implant placement, however, may extend treatment time. When applying 1stage protocols, loading forces exceeding 150 microns may have detrimental effects in the
healing phase. Troiano et. al. in 2018 conducted a systematic review to compare between
success rates of 1-stage versus 2-stage implant healing. Their results showed that 1-stage
implants have a 2% higher early failure rate than 2-stage implants.
Linkevicius and colleagues, in 2009, evaluated the effect of soft tissue thickness on periimplant bone levels. Their study showed that up to 1.45 mm of crestal bone loss may be
expected when soft tissue thickness was less than 2 mm.53
Kumar and colleagues in 2018 conducted a retrospective analysis of 222 single implants in
86 patients to assess site-level risk predictors of peri-implantitis, while controlling for
patient level variables. They reported that a baseline plaque index of 1.6 or greater, history
of tooth loss due to periodontitis, periodontal disease on adjacent teeth, deep implant
placement and asymmetric prosthesis were all associated with peri-implantitis
occurrence.54
According to the 2017 world workshop on the classification of periodontal and periimplant diseases and conditions, major risk indicators for peri-implantitis are poor plaque
control, history of severe periodontitis and lack of regular maintenance care.9
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The purpose of this retrospective study was to assess the validity of using a computer-based
periodontal risk calculator (PRC) score to assess the risk of developing peri-implantitis in
the future.
For the determination of risk scores, PRC requires information about patient age, history
of smoking, diabetes, history of periodontal surgery, pocket depth, bleeding on probing,
restoration below the gingival margin, root calculus, radiographic bone height, furcation
involvements, and vertical bone lesions. A 15-year follow up study reported PRC to have
a high level of accuracy in predicting the risk of periodontal bone loss and tooth loss.20
Predicting future development of peri-implantitis before its occurrence could help dentists
in making better treatment planning decisions and reducing treatment costs for patients.
PRC could also help switch from the currently used repair to the wellness model of
treatment during implant therapy.
The null hypothesis for this study was that patients with higher PRC scores are not at
elevated risk for developing peri-implantitis.
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MATERIAL AND METHODS

In this retrospective study, the patient population included patients (>20 years of age) who
had implants placed and restored at Marquette University School of Dentistry (MUSOD)
from 2008 to 2016. Further, the restored implants in these patients must have been in
function for at least one year and followed up in the school with clinical and radiographic
examinations. Patients excluded from the study were those who had radiation therapy, or
any patients who did not have acceptable radiographs for proper documentation. Before
collecting data from patients' existing records, approval was obtained from MUSoD's
Institutional Review Board.

Patient records were screened from a list of 1,496 patients who had 3,032 implants placed
at the school between the mentioned period. A total of 112 implants placed in 83 patients
were included for analysis. Eighty-two implants positive for peri-implantitis were included
in the test group and 30 implants negative for peri-implantitis were included in the control
group.
Peri-implantitis was diagnosed according to Lang & Berglundh criteria, based on the
stability of the radiographic bone level and clinical findings after loading of the implant
prosthesis.42 Patients were diagnosed with peri-implantitis if there was evidence of
progressive bone loss around an implant with bleeding on probing and/or suppuration.
PRC records for the patients were retrospectively calculated within the same year of
implant placement or, one year before implant placement. In addition, multiple variables
were recorded including patient age, gender, smoking history, diabetes, hypertension,
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presence or absence of periodontal disease, site of implant placement, type of restoration,
radiographic bone height, implant information (brand, length and diameter), staging, bone
grafting prior to placement, bone grafting at the time of placement, immediate vs. delayed
implant placement.
A baseline measurement was made using radiographs by measuring the bone level on the
mesial and distal aspects at least one year after loading. The comparison was made using
radiographs made in the most recent follow-up appointment. Bitewing radiographs were
used for measurement when present. When bitewing radiographs were not available,
periapical radiographs were used to measure the bone level. For a bone-level implant, bone
loss was measured from the implant shoulder to the crestal bone. For Straumann tissuelevel implants, measurements were made similarly; however, the polished collar of the
implant was subtracted from the measurements based on the known height of the polished
collar.
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Figure 1. Showing mesial and distal crestal bone level measurements for Straumann
4.1x10mm Standard plus tissue level implant at baseline. 1.8mm is subtracted from each
of the measurements for this implant to account for the polished collar resulting in a final
recording of 0.05mm and 0.18mm of bone loss on the mesial and distal aspects,
respectively.
Statistical analysis:
All the patient characteristics and implants parameters were described using descriptive
statistics. All category variables were described as frequency and percentage and two
groups of patients (or implants) with or without disease were compared using Chi-Square
or Fisher exact test wherever appropriate. Similarly, all the continuous numeric variables
were described as mean and standard deviation and the two groups were compared using
two-tailed t-test. For the comparison of bone loss across the 5 PRC categories, one-way
ANOVA was used and for multiple comparisons, Bonferroni test was used. For time-toevent (time in years of follow-up and event being peri-implantitis or no peri-implantitis)

21
analysis was done using multivariate Cox regression. For Cox regression implant
characteristics were used as covariates. For all statistical test alpha of 0.05 significance
level was used. Statistical analysis was performed using SAS version 9.4 (STAT 15.1),
SAS Institute, Cary, NC.
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RESULTS

The mean age of the patients was 68.49 and ranged from 36 – 97 years of age. Binary
genders were evenly distributed among the groups. No statistically significant difference
was found between the peri-implantitis and peri-implant health groups with regard to
smoking habits, history of diabetes or age, while hypertension was significantly more
common in the peri-implantitis group.

Figure 2. Periapical radiograph showing advanced peri-implantitis lesions with
crater like appearance on two adjacent Nobel Biocare implants, restored with cement
retained lithium disilicate crowns on titanium custom abutments.
At the implant level, no statistically significant difference was found for site, bone grafting
before or at the time of placement, delayed vs immediate placement, 1 stage vs 2 stage or
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type of restoration. Most of the implants were restored with cement-retained restorations
(89%).

All cases with PRC of 1 were in the control group while all cases with PRC of 4 and 5 were
in the test group. Average proximal bone loss was significantly correlated with PRC scores.
The patients with higher PRC scores had more average proximal bone loss when measured
radiographically. Average proximal bone loss in the control group was 0.11mm and in the
peri-implantitis group was 2.48 mm.

Figure 3. Periapical radiograph of 4.3 x 10 mm Nobel Biocare, active implant
supporting a mandibular fixed detachable prosthesis and displaying >50% bone loss
on the mesial and distal aspects.
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Figure 4. (A) Baseline radiograph of 4.3 x 10 mm Nobel Replace implant restored
with cement retained porcelain fused to metal crown # 30. 2-3mm of bone loss was
noted after 1 year of function due to initial remodeling. (B) Latest radiograph made
after 7 years of function. Severe bone loss is seen on the mesial and distal aspects.
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Characteristics

Total (N=83 patients
with 112 implants)

Control (N=22 patients and
30 implants)

Test (N=61 patients and 82
implants)

P Value

N

%

N

%

N

%

47
36

56.63
43.37

11
11

23.40
30.56

36
25

76.60
69.44

17
62
4

20.48
74.70
4.82

5
16
1

29.41
25.81
25.00

12
46
3

70.59
74.19
75.00

73
10

87.95
12.05

18
4

24.66
40.00

55
6

75.34
60.00

0.3026

52
31

62.65
37.35

18
4

34.62
12.90

34
27

65.38
87.10

0.0302

69
43

61.61
39.39

16
14

23.19
32.56

53
29

76.81
67.44

5
84
5
11
7

4.46
75.0
4.46
9.82
6.25

2
16
0
10
2

40.0
19.16
0.0
90.91
28.57

3
68
5
1
5

60.0
80.95
100.0
9.09
71.43

87
25

77.68
22.32

21
9

24.14
36.00

66
16

75.86
64.00

0.2378

Bone graft at implant
No
Yes

74
38

66.07
33.93

18
12

24.32
31.58

56
26

75.68
68.42

0.4117

Implant diameter
Narrow (< 4mm)
Regular (4-4.5mm)
Wide (> 4.6mm)

1
68
43

0.89
60.71
38.39

1
24
5

100.00
35.29
11.63

0
44
38

0.00
64.71
88.37

0.0059

PRC
Score 1
Score 2
Score 3
Score 4
Score 5

7
32
9
33
2

8.43
38.55
10.84
39.76
2.41

7
10
2
3
0

100.00
31.25
22.22
9.09
0.00

0
22
7
30
2

0.00
68.75
77.78
90.91
100.00

<.0001

Placement
Delayed
Immediate

92
20

82.14
17.86

27
3

29.35
15.00

65
17

70.65
85.00

0.1891

Site
Ant Mand
Ant Max
Post Mand
Post Max

2
9
36
36

2.41
10.84
43.37
43.37

0
3
10
9

0.00
33.33
27.78
25.00

2
6
26
27

100.00
66.67
72.22
75.00

0.7992

74
9

89.16
10.84

19
3

25.68
33.33

55
6

74.32
66.67

0.6231

68.49

13.68

66.91

15.21

69.07

13.17

0.5295

Gender
Female
Male
Smoking
Former Smoker
Non- Smoker
Current Smoker
Diabetes
No
Yes
Hypertension
No
Yes
Staging (Implants)
1 stage
2 stage
Implant brand
Astra
NB
NB active
ST BLT
ST TL
Bone graft before implant
No
Yes

0.4644

0.9541

0.2762

<0.001

Cement vs screw retained
restoration
Cement
Screw
Age (Mean and SD)

Table 2. Showing patient characteristics for control and test group.
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Dependent Variable: Average bone loss

Source

DF

Sum of
Squares

Mean
Square

F Value

Pr > F

Model
Error
Corrected Total

4
107
111

34.72
228.90
263.62

8.68
2.14

4.06

0.0042

Table 3. ANOVA procedure for average bone loss.

PRC

N

Average bone loss
Mean
Std Dev
0.10
0.14

1

10

2

47

1.93

1.81

3

12

1.87

1.30

4

40

2.15

1.23

5

3

2.07

0.68

Table 4. Descriptive statistics for average bone loss across five PRC categories.
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Figure 5. Box plots for average bone loss across five PRC categories.
There was a significant correlation towards increased bone loss measurements as PRC
scores increased. PRC scores of 4 and 5 experienced the most severe bone loss with an
average of 2.15 and 2.07mm, respectively. Patients with PRC scores of 1 had minimal to
no

bone

loss

with

an

average

measurement

of

0.10mm.

The PRC scores showing the highest frequency were 2 and 4. PRC scores of 2 had the
highest standard deviation while PRC scores of 1 had the lowest. Thus, PRC scores of 1
consistently showed minimal levels of bone loss while PRC scores of 2 showed high
variability.
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Analysis Variable: Follow up Time (Control)
PRC
N
Mean
Std Dev
1
10
6.45
2.76
2
14
5.94
3.08
3
2
5.36
3.80
4
4
3.77
1.24

Table 5. Descriptive statistics for follow up time across PRC categories for control
group.
Analysis Variable: Follow up Time (Test)
PRC
N
Mean
Std Dev
2
33
4.19
2.76
3
10
3.78
2.45
4
36
3.36
2.28
5
3
3.49
1.52

Table 6. Descriptive statistics for follow up time across PRC categories for test group.
For the control groups, follow up times where calculated from time of implant placement
to latest follow-up. For the test group, follow-up was tabulated from the time of implant
placement until the disease occurrence. Average follow-up times ranged from 3.36-6.45
years. PRC scores of 4 and 5 had the fastest occurrence of disease from time of implant
placement. PRC scores of 1 had the longest disease-free follow-up. For the control group
each PRC category showed a longer average duration of function than the corresponding
category in the test group.
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Variable

Reference
Category

Hazard ratio

95% Hazard Ratio
Confidence
Interval
Lower
Upper
1.06
1.45

Average Bone
1.24
Loss
1 Stage
2 Stage
1.47
0.81
Implant brand NB
1.49
0.41
Astra
Implant brandNB
1.25
0.27
NB Active
Implant brandNB
0.10
0.01
ST BLT
Implant brandNB
1.10
0.41
ST TL
PRC score
1.69
1.32
Bone Grafting
Y
0.96
0.51
Before Implant
Placement
Diameter Regular
0.00
0.00
Narrow
Diameter- Wide
Regular
1.35
0.81
Bone Grafting at
No
2.75
1.28
the time of
Implant
Placement
Delayed
Immediate
2.07
0.86
Screw retained
Cement
4.16
1.89
Table 7. Cox Regression predicting hazards for peri-implantitis.

Average bone loss
Group
Control

Total

PRC

N

Mean

Std Dev

1

10

0.1

0.14

2

14

0.09

0.19

3

2

0

0

4

4

0.25

0.35

30

0.11

0.2

Table 8. Average bone loss for control group.

P value

0.0074

2.68
5.45

0.2070
0.5439

5.74

0.7721

0.81

0.0312

2.92

0.8476

2.16
1.79

<.0001
0.8928

0.00

0.9851

2.23
5.94

0.2514
0.0099

4.96
9.16

0.1031
0.0004
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Average bone loss
Group
Test

PRC

N

Mean

Std Dev

2

33

2.71

1.6

3

10

2.24

1.06

4

36

2.36

1.11

5

3

2.06

0.68

82

2.48

1.31

Total

Table 9. Average bone loss for test group.
PRC

N

Average bone loss
Time to Peri-implantitis
Mean
Std Dev
Mean
Std Dev
1
10
0.1
0.14
6.45
2.76
2
47
1.93
1.81
4.71
2.94
3
12
1.86
1.30
4.04
2.57
4
40
2.15
1.23
3.40
2.19
5
3
2.07
0.68
3.49
1.52
Table 10. Average bone loss and time to peri-implantitis diagnosis date.
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DISCUSSION
The null hypothesis in this study was rejected as the statistical analysis showed that patients
with higher PRC scores were more likely to have peri-implantitis. This correlation was
statistically significant and most notable for the high PRC values. Implants with PRC
values of 1 were negative for peri-implantitis in 100% of the subjects while implants with
PRC values of 4 and 5 were positive for peri-implantitis in 100% of the subjects. This
information may be beneficial when planning for implant therapy, especially since the PRC
can also aid in predicting risk of periodontal disease progression around teeth. PRC
analysis can help plan therapy for patients with periodontal disease as well as give an
indication of potential risk of peri-implant disease in these patients.

The results of the current study found that there was no statistically significant difference
between smokers and non-smokers with regards to prevalence of peri-implantitis.

The results from previous studies such as Haas et al. and Lindquist et al. demonstrated that
smoking results in higher level of bone loss around implants and that this relationship may
be dose dependent.36,37 Al Harthi and colleagues, in 2017, showed that in waterpipe
smoking was also significantly correlated with peri-implantitis.38 The current study did not
include waterpipe smoking as a separate entity and many waterpipe smokers may not
consider themselves as smokers. This may underestimate the number of smokers actually
included in the study.
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This study did not find a significant correlation between diabetes and peri-implantitis. This
is in contrast to the results presented by Monje and co-workers in 2017. Their systemic
review data showed that diabetic patients were at 50% higher risk of developing periimplantitis with a dose-dependent relationship to baseline HBA1c level.39

In this study, implant site, bone grafting before or at the time of placement, delayed vs
immediate placement, 1-stage vs 2-stage procedures did not seem to influence the
incidence of peri-implantitis. These findings are consistent with the results of Kim and
colleagues in their retrospective study of 184 implants they found no correlation for any of
the above-mentioned variables to bone loss around implants.43
Shin and wo-workers, in 2006, showed reduced crestal bone loss around roughened surface
implants as compared to machined surface.45 The current study only included roughened
surface implants, with the exception of the polished collar on Straumann tissue-level
implants. While different surface treatments may have different biological responses over
time, most of the implants in the current study where Nobel Biocare implants utilizing the
same TiUnite surface. Therefore, the impact of different surfaces on the results of this study
could not be evaluated. The TiUnite surface is a moderately rough titanium oxide layer that
has been extensively studied and has demonstrated clinical success over time.55

Susarla and colleagues, in 2008, found that immediately loaded implants are 2.7 times more
likely to fail at 1 year than conventionally loaded implants.47 The current study found no
such correlation. While several authors stated that crestal bone loss after immediate implant
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placement is an expected clinical outcome49,51, this was not corroborated by the current
study.

In the current study, bone grafting before or at the time of implant placement showed no
correlation to bone loss or the occurrence of peri-implantitis. Whether long term survival
rates of implants in augmented sites is different from non-augmented sites is still
controversial.44 Boronat and co-workers in 2010 presented clinical outcomes of 129
implants placed with simultaneous autogenous block grafts. They found the mean bone
loss after 1 year of loading to be 0.64 mm.56 Ramanauskaite et. al. in 2018 assessed grafted
versus non grafted implant sites response to peri-implantitis therapy. Their findings showed
that combined augmentative therapy with implantoplasty had similar results for implants
that were placed in grafted and nongrafted sites.57 Lin and co-workers, in 2018, found that
implant failures after occlusal loading has occurred were significantly more common in
patients that had bone augmentation procedures done.44

As for soft tissue thickness, a minimum of 2mm is required to reduce chances of crestal
bone loss according to Linkevicius and colleagues, in 2009. This could not be evaluated in
the current study.53

The current study found hypertension and implant diameter to be correlated with periimplantitis. This may be an overstatement as there are too many confounding factors that
play a role in the development of this disease.28 Further, most implants included in the study
were regular and wide diameter with the exception of one narrow diameter implant.
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It is important to note that due to the strict inclusion criteria and the nature of patients’
compliance with follow up appointments within the school, the sample size of this study
was reduced from what had been anticipated. This may have affected the data and statistical
analysis leading to possible under or over-estimation of the results. Furthermore, patients
with a PRC of 1 and 5 had the lowest number of subjects included. This may be due to the
fact that most patients with PRC 1 don’t have a demand for implants, while most patients
with PRC 5 may be regarded as poor candidates for implants and so were treated with
alternative methods.

One main limitation of this study is that it is a single center study where only patients that
had complete records for analysis were included. Subjects that were included in the study
had variable follow- up intervals which made it difficult to add a time factor to the analysis
of bone loss. Had there been more consistent follow up intervals, severity of bone loss in
relation to time could have been analyzed for each PRC group.

Another limitation is that the technique for radiograph acquisition could not be
standardized due to the retrospective nature of the study. Further, the measurements were
made on the available radiographs which were mostly bitewings, and in some instance
periapical radiographs. This was accounted for by making sure the digital ruler on the
radiograph was always calibrated before each measurement, using objects of known size.
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Several other limitations were encountered during the course of this study. Firstly, most
implants placed in the dental school were Nobel Biocare implants. This led to a significant
bias towards this implant brand and impeded efforts to perform statistical analysis across
the different brands of implants in relation to peri-implantitis. Secondly, most of the
implants restored in the school were restored by pre-doctoral students with minimal
experience in implant dentistry. Although this process occurs under close supervision of
the faculty, there may still be a confounding factor that limits generalization of these
finding to the general public. Moreover, owing to its simplicity, most of the implants were
restored with cement retained restorations. Excess cement left behind from the cementation
procedure is a known risk factor for peri-implantitis.29,30 This may be more likely due to
the already stated inexperience of the students. It should be noted that excess cement and
not the cemented restoration itself is the risk factor.
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SUMMARY AND CONCLUSIONS
Within the limitations of the study, the following conclusions can be drawn,
1. Periodontal risk calculator may be used to predict risk of periimplantitis occurrence
and degree of radiographic proximal bone loss around dental implants.
2. Higher PRC scores were correlated with higher bone loss and lower PRC scores were
correlated with reduced severity of bone loss.
3. Site, bone grafting before or at the time of placement, delayed vs immediate placement,
1-stage vs 2-stage procedures did not influence incidence of peri-implantitis.
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